Table 3.

IC50 values for chlorambucil or fludarabine alone or in the presence of HMA


Patient no.

IC50, μM
HMA
Chl
Chl/HMA, 100:1
Flu
Flu/HMA, 10:1
1   1.2   24.2   23   3.3   4  
2   0.45   61.8   12.6*  1.2   0.77  
3   0.86   167   8.9*  5.4   1.3  
4   0.46   68.6   16.3*  3.3   1.6  
5   0.31   27.8   18.4   2.0   1.1  
6   0.65   50.9   26.6   7.5   3.3 
7   0.09   8.8   5.1   0.76   0.27 
8   0.541   60.5   20.7  1.2   1.3  
9   0.04   20.2   4.0*  0.38   0.29  
10   0.14   13.2   14.6   2.6   1.9  
11   0.24   13.3   10.8   1.1   0.6  
12   0.16   10.7   6.2   0.68   0.73  
13
 
0.06
 
5.3
 
4.1
 
0.77
 
0.34
 

Patient no.

IC50, μM
HMA
Chl
Chl/HMA, 100:1
Flu
Flu/HMA, 10:1
1   1.2   24.2   23   3.3   4  
2   0.45   61.8   12.6*  1.2   0.77  
3   0.86   167   8.9*  5.4   1.3  
4   0.46   68.6   16.3*  3.3   1.6  
5   0.31   27.8   18.4   2.0   1.1  
6   0.65   50.9   26.6   7.5   3.3 
7   0.09   8.8   5.1   0.76   0.27 
8   0.541   60.5   20.7  1.2   1.3  
9   0.04   20.2   4.0*  0.38   0.29  
10   0.14   13.2   14.6   2.6   1.9  
11   0.24   13.3   10.8   1.1   0.6  
12   0.16   10.7   6.2   0.68   0.73  
13
 
0.06
 
5.3
 
4.1
 
0.77
 
0.34
 

The patient numbers are as described in the first column of Table 2.

*

Isolates whose IC50 was decreased by more than 75% in the presence of HMA.

Isolates whose IC50 was decreased by more than 50% in the presence of HMA.

Close Modal

or Create an Account

Close Modal
Close Modal